Infokiri

Dokumendiregister Terviseamet
Viit 8-2/25/349-1
Registreeritud 15.01.2025
Sünkroonitud 16.01.2025
Liik Sissetulev dokument
Funktsioon 8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine
Sari 8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus
Toimik 8.1-2/2025
Juurdepääsupiirang Avalik
Juurdepääsupiirang
Adressaat ARHAI
Saabumis/saatmisviis ARHAI
Vastutaja Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond)
Originaal Ava uues aknas

Failid

E-kiri.eml
image001.gif
image002.gif
image003.png
image004.gif
image005.gif
image006.png

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.


 

To: National Focal Points (NFPs) (and Alternates) for Antimicrobial Consumption; Operational Contact Points (OCPs) for Epidemiology/TESSy Interactions - Antimicrobial Consumption (AMC)

CC: National Coordinators (Coordinating Competent Bodies)

 

 

Dear colleagues,

 

As mentioned in our email of 21 November 2024, the process of appointing a new Disease Network Coordination Committee (DNCC) for the European Surveillance of Antimicrobial Consumption Network (ESAC-Net), has started.

 

Ten (10) members of ESAC-Net have submitted their candidature to become a member of the new ESAC-Net DNCC.

 

As described previously, in case there is no more than ten candidates, ECDC agreed to send the names of the candidates to all NFPs and OCPs from the corresponding network asking for any major objection to the entire proposed list of members of the DNCC.

 

The PROPOSED LIST OF MEMBERS OF THE ESAC-Net DNCC is as follows:

 

Name

Country

Functional expertise

Role in ESAC-Net

Majda Attauabi

Denmark

AMC/AMR surveillance

NFP (AMC)

Jan Baltink

The Netherlands

Pharmacy

NFP (AMC) alternate, OCP for epidemiology

Hege Salvesen Blix

Norway

AMC surveillance

NFP (AMC), OCP for TESSy

Lucy Catteau

Belgium

AMC surveillance

NFP (AMR, AMC) alternate, OCP for epidemiology

Catherine Dumartin

France

Surveillance, pharmacy

OCP for epidemiology

Emre Umut Gürpınar

Ireland

Epidemiology

OCP for epidemiology, microbiology, TESSy

Anna Olczak-Pieńkowska

Poland

AMC surveillance

OCP for microbiology

Birgitta Schweickert

Germany

Clinical microbiology and epidemiology, AMC surveillance

NFP (AMC) alternate, OCP for epidemiology

Maja Šubelj

Slovenia

Epidemiology

NFP (AMC), OCP for epidemiology

Peter Zarb

Malta

Clinical pharmacy

OCP for TESSy, NFP (AMC) alternate

 

 

If you have a major objection to the entire proposed list, please indicate so by replying to this email by Friday 31 January 2025 COB. If no objection is received by this date, we will proceed with the appointment of the DNCC by the ECDC Director.

 

If you have any questions, please do not hesitate to contact us at arhai@ecdc.europa.eu

 

Yours sincerely,

ECDC ARHAI Section

 

 

 

 

European Centre for Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 10 00

www.ecdc.europa.eu

Follow ECDC on: 

 


Classified as ECDC NORMAL 

From: ARHAI
Sent: 21 November 2024 13:50
To: reinhild.strauss@gesundheitsministerium.gv.at; Boudewijn.catry@sciensano.be; lucy.catteau@sciensano.be; ivanoov@gmail.com; ivanstoikovbt@gmail.com; marina.payerl-pal@zzjz-ck.hr; damjan.debelec@gmail.com; ikyriakidou@phs.moh.gov.cy; ckontemeniotou@phs.moh.gov.cy; Lenka.Vostalova@uzis.cz; Tomas.Majek@uzis.cz; maat@ssi.dk; lau@sundhedsdata.dk; janne.sepp@ravimiamet.ee; Katrin.Kurvits@ravimiamet.ee; emmi.sarvikivi@thl.fi; tinna.voipio@fimea.fi; ghaya.benhmidene@santepubliquefrance.fr; karima.hider-mlynarz@ansm.sante.fr; Abu-SinM@rki.de; SchweickertB@rki.de; a.maragkos@eody.gov.gr; k.mellou@eody.gov.gr; hajdu.agnes2@nngyk.gov.hu; mmatuz@gmail.com; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; susanna.frost@hpsc.ie; phil.downes@hpsc.ie; ARHAI@hpsc.ie; mp.trotta@aifa.gov.it; f.fortinguerra@aifa.gov.it; Ieva.Saliete@zva.gov.lv; ieva.voita@spkc.gov.lv; andis.seilis@zva.gov.lv; esther.walser-domjan@llv.li; rolanda.valinteliene@hi.lt; martine.debacker@ms.etat.lu; stephanie.saleh@ms.etat.lu; daniel.alvarez@ms.etat.lu; michael.a.borg@gov.mt; peter.zarb@gov.mt; Jan.Baltink@radboudumc.nl; sabine.de.greeff@rivm.nl; hege.salvesen.blix@fhi.no; a.skoczynska@nil.gov.pl; kpawlik@szpital-lebork.com.pl; a.skoczynska@nil.gov.pl; joana.fernandes@infarmed.pt; ppcira@dgs.min-saude.pt; gabriel.popescu@umfcd.ro; roxana.serban@insp.gov.ro; tesar@fpharm.uniba.sk; Maja.Subelj@nijz.si; zoran.simonovic@nijz.si; alopezn@aemps.es; mpeinado_externo@aemps.es; andreas.sandgren@folkhalsomyndigheten.se; petra.edquist@folkhalsomyndigheten.se; alma.brolund@folkhalsomyndigheten.se; hajdu.agnes2@nngyk.gov.hu; deptula.aleksander@gmail.com; ales.korosec@nijz.si; hoffmanna@rki.de; andis.seilis@zva.gov.lv; A.Pierantozzi@aifa.gov.it; Angela.Lehner@gesundheitsministerium.gv.at; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; aolczak-pienkowska@wim.mil.pl; alopezn@aemps.es; akontemeniotis@phs.moh.gov.cy; Løvlie, Astrid Louise <Astrid.Louise.Lovlie@fhi.no>; SchweickertB@rki.de; boyka_markova@yahoo.com; brendand@landspitali.is; carina.brehony@hpsc.ie; catherine.dumartin@chu-bordeaux.fr; ckontemeniotou@phs.moh.gov.cy; christine.hain@sozialministerium.at; c.santini@aifa.gov.it; c.santini@aifa.gov.it; cgutierrez@isciii.es; damjan.debelec@gmail.com; David.Neumayer@bmg.gv.at; utbrudd@fhi.no; Eirik.olsen@fhi.no; ellen.mcloughlin@hpsc.ie; emmi.sarvikivi@thl.fi; umut.gurpinar@hpsc.ie; umut.gurpinar@hpsc.ie; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; etienne.lucas@santepubliquefrance.fr; gabriel.popescu@umfcd.ro; gabriela.elbelazi@gesundheitsministerium.gv.at; geantoniou@phs.moh.gov.cy; gerard.scheiden@ms.etat.lu; ghaya.benhmidene@santepubliquefrance.fr; gudrun.aspelund@landlaeknir.is; hege.salvesen.blix@fhi.no; hege.salvesen.blix@fhi.no; helena.sebestova@szu.cz; ai@wido.bv.aok.de; hildigunnur.a.hall@landlaeknir.is; hildigunnur.a.hall@landlaeknir.is; Ieva.Saliete@zva.gov.lv; Ieva.Saliete@zva.gov.lv; ineta.pranskunaite@hi.lt; ionel.iosif@insp.gov.ro; isabel.cuesta@isciii.es; iva.vlckova@szu.cz; ivanstoikovbt@gmail.com; administrator@ncipd.org; Jan.Baltink@radboudumc.nl; jana.namesna@uvzsr.sk; jan-erik.loflund@thl.fi; janne.sepp@ravimiamet.ee; j.bysiek@nil.gov.pl; Jiri.Jarkovsky@uzis.cz; joana.fernandes@infarmed.pt; j.paulo.gomes@insa.min-saude.pt; Jorge.machado@insa.min-saude.pt; julien.durand@santepubliquefrance.fr; Katrin.Kurvits@ravimiamet.ee; kenan.ajanovic@wido.bv.aok.de; kras_ivanova@abv.bg; laura.bonacini@sciensano.be; LiveStorehagen.Dansie@fhi.no; lucy.catteau@sciensano.be; MagnusWenstop.Ogle@fhi.no; lau@sundhedsdata.dk; lau@sundhedsdata.dk; Maja.Subelj@nijz.si; mpeinado_externo@aemps.es; mpeinado_externo@aemps.es; feigM@rki.de; Mari.Molvik@fhi.no; mjalbuquerque@dgs.min-saude.pt; mmatuz@gmail.com; mmatuz@gmail.com; mp.trotta@aifa.gov.it; mp.trotta@aifa.gov.it; marianna.thordardottir@landlaeknir.is; marianna.thordardottir@landlaeknir.is; marie.philbin1@hse.ie; michael.a.borg@gov.mt; mpc@pzh.gov.pl; M.Roukens@akf.umcn.nl; Abu-SinM@rki.de; ppcira@dgs.min-saude.pt; ppcira@dgs.min-saude.pt; ppcira@dgs.min-saude.pt; ppcira@dgs.min-saude.pt; olafur@landlaeknir.is; budavari.olga@nngyk.gov.hu; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; peter.zarb@gov.mt; ragda.obeid@folkhalsomyndigheten.se; ragda.obeid@folkhalsomyndigheten.se; ragnhild.raastad@fhi.no; raqueleusebio@dgs.min-saude.pt; benkoria@gmail.com; roberto.dacas@iss.it; roxana.serban@insp.gov.ro; sineadodonnell2@beaumont.ie; ssy@ssi.dk; FuchsS@rki.de; stephanie.saleh@ms.etat.lu; Stephen.Murchan@hpsc.ie; Stephen.Murchan@hpsc.ie; susanna.frost@hpsc.ie; tanja.kustec <tanja.kustec@nijz.si>; teemu.mottonen@thl.fi; EckmannsT@rki.de; tinna.voipio@fimea.fi; tesar@fpharm.uniba.sk; SemmlerT@rki.de; vsilvestros@ns.moh.gov.cy; viktoras.bumsteinas@nvsc.lt; w.hryniewicz@nil.gov.pl; warren.a.bruno@gov.mt; yves.dupont@sciensano.be; farkas.zsolt@nngyk.gov.hu
Cc: NC_CCB_Austria@bmg.gv.at; sigrid.kiermayr@gesundheitsministerium.gv.at; koen.blot@sciensano.be; ccb@sciensano.be; getsova@ncipd.org; iva_christova@ncipd.org; kcapak@hzjz.hr; bernard.kaic@hzjz.hr; econstantinou@moh.gov.cy; ECDC_NIPH@szu.cz; hana.orlikova@szu.cz; kgrl@sst.dk; Suja@sst.dk; kart.sober@terviseamet.ee; julia.geller@terviseamet.ee; info@terviseamet.ee; otto.helve@thl.fi; carita.savolainen-kopra@thl.fi; Paula.garcia-lobato@santepubliquefrance.fr; anne-catherine.viso@santepubliquefrance.fr; RathmachersL@rki.de; ecdc@rki.de; RexrothU@rki.de; anderheidenma@rki.de; t.kalomama@eody.gov.gr; d.paraskevis@eody.gov.gr; ch.chatzichristodoulou@eody.gov.gr; danielisz.agnes@nngyk.gov.hu; phc.office@nngyk.gov.hu; rezsofi.judit@nngyk.gov.hu; gudrun.aspelund@landlaeknir.is; lois.oconnor@hpsc.ie; aine.grace@hpsc.ie; patricia.garvey@hpsc.ie; louise.cullen@hpsc.ie; lisa.domegan@hpsc.ie; f.maraglino@sanita.it; antra.bormane@spkc.gov.lv; silvia.dehler@llv.li; jurgita.pakalniskiene@sam.lt; greta.gargasiene@nvsc.lt; jurgita.pakalniskiene@sam.lt; jean-claude.schmit@ms.etat.lu; charmaine.gauci@gov.mt; Hester.de.Melker@rivm.nl; susan.van.den.hof@rivm.nl; emilyann.macdonald@fhi.no; heidi.lange@fhi.no; kzacharczuk@pzh.gov.pl; marianaferreira@dgs.min-saude.pt; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; cesp@dgs.min-saude.pt; aperaltasantos@dgs.min-saude.pt; Adriana Pistol <adriana.pistol@ms.ro>; lucia.paulikova@uvzsr.sk; ecdc@uvzsr.sk; maja.socan@nijz.si; ecdcinfo@nijz.si; fsimon@sanidad.gob.es; ecdc.sweden@folkhalsomyndigheten.se; ecdc.support@folkhalsomyndigheten.se; agneta.falkfilipsson@folkhalsomyndigheten.se; sara.bengtsson@folkhalsomyndigheten.se; Birgitta.Lesko@folkhalsomyndigheten.se; anette.richardson <anette.richardson@folkhalsomyndigheten.se>; Country Cooperation <Country.Cooperation@ecdc.europa.eu>; DPR ARHAI <DL_DPR_ARHAI@ecdc.europa.eu>
Subject: FOR ACTION - Call for candidates: Members of ESAC-Net Disease Network Coordination Committee

 

To: National Focal Points for Antimicrobial Consumption; Operational Contact Point for Epidemiology/TESSy Interactions - Antimicrobial Consumption (AMC)

CC: National Coordinators (Coordinating Competent Bodies)

 

Dear colleagues,

 

The mandate period for Disease Network Coordination Committee (DNCC) for the European Surveillance of Antimicrobial Consumption Network (ESAC-Net), appointed for the term February 2022 – February 2025, is coming to an end. We would like to take the opportunity to thank ESAC-Net DNCC members who have served during this term: Majda Attauabi, Hege Salvesen Blix, Lucy Catteau, Catherine Dumartin, Maja Laursen, Stephanie Natsch, Anna Olczak-Pieńkowska, Maja Šubelj and Peter Zarb.

 

It is now time to appoint a new ESAC-Net DNCC, to serve for the mandate of three years (March 2025 – February 2028). With this email, we would like to announce the call for candidates for members of the new DNCC. The generic terms of reference for ECDC’s Disease Network Coordination Committees are attached.

 

According to these official generic terms of reference:

“The Disease Network Coordination Committees (DNCCs) shall support further development of the ECDC disease work and networks, by providing important but non-binding advice to respective ECDC Disease Programmes (DPs) with respect to all aspects of its work including surveillance, prevention and control or any other technical, epidemiological or scientific aspects, thus enabling the network to improve its effectiveness and added value.”

 

The DNCC consists of a maximum of ten members, and it is recommended that both NFPs and OCPs are represented in the DNCC. Furthermore, according to the terms of reference, it is also recommended that the DNCC should aim for a balance between functional expertise, gender, and geography.

 

If you are interested to join the ESAC-Net DNCC as a member, please respond to this emailarhai@ecdc.europa.eu – indicating your name, role in the ECDC Competent Bodies structure (NFP or OCP), functional expertise, as well as the EU/EEA country that you represent.

 

Furthermore, please feel free to propose another NFP/OCP whom you would like to see as a member of the DNCC. ECDC will then approach this person to see if they are available. If not enough volunteers come forward (or if there is a need to balance the composition of the Coordination Committee in terms of geography, gender, and expertise), ECDC may identify and approach individuals asking for their candidacy.

 

The call for nominations is open until Thursday 19th December 2024 (close of business).

 

ELECTION PROCEDURE

  • If there are no more than ten candidates who expressed their interest in serving on the DNCC (and there is a good balance between geography, gender, and function), ECDC will send the names of the candidates to all NFPs and OCPs asking for any major objections to the entire proposed list of members to the DNCC.

    • If there are no major objections to the proposal as a whole, we will move forward with having the DNCC officially appointed by the ECDC Director.

    • If there are major objections to the proposal, we will arrange an electronic election, in which we will ask the NFPs to coordinate a vote yes/no (one vote per Member State) for the entire proposed list. If there is a majority support for the list, we will move forward with having the DNCC officially appointed by the ECDC Director. If there is no majority support for the proposed list, we will start the election process over.

  • If there are more than ten candidates who expressed their interest in serving on the DNCC, we will arrange an electronic election, in which we will task the NFPs to coordinate a vote (one vote per Member State) for ten candidates from the candidates list. The ten candidates with the most votes will be elected to the DNCC, and we will move forward with having the DNCC officially appointed by the ECDC Director.

 

Should you have any questions, please don’t hesitate to contact us at arhai@ecdc.europa.eu

 

We look forward to receiving your candidacy for a member of the ESAC-Net DNCC!

 

Best regards,

ECDC Antimicrobial Resistance and Healthcare-associated Infections Section

 

 

European Centre for Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 10 00

www.ecdc.europa.eu

Follow ECDC on: 

 


Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.